Showing items 1–100
Solid forms of isoquinolinones, and process of making, composition comprising, and…
Grant US-11939333-B2
United States of America
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
Grant US-11905332-B2
United States of America
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
Grant US-11896616-B2
United States of America
End-to-end cell therapy automation
Grant US-11827902-B2
United States of America
Peritumoral and intratumoral materials for cancer therapy
Grant US-11786457-B2
United States of America
End-to-end cell therapy automation
Grant US-11781113-B2
United States of America
Cell concentration methods and devices for use in automated bioreactors
Grant US-11773365-B2
United States of America
Recapitulating the hematopoietic niche to reconstitute immunity
Grant US-11752238-B2
United States of America
Automated production of viral vectors
Grant US-11718833-B2
United States of America
Carousel for modular biologic production units
Grant US-11714096-B2
United States of America
Methods for expanding immune cells
Grant US-11673937-B2
United States of America
Cell culture and tissue engineering systems with controlled environmental zones
Grant US-11597905-B2
United States of America
Immune cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof
Grant US-11560548-B2
United States of America
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
Grant US-11555177-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-11541059-B2
United States of America
End-to-end cell therapy automation
Grant US-11447745-B2
United States of America
Certain chemical entities, compositions and methods
Grant US-11433065-B2
United States of America
End-to-end cell therapy automation
Grant US-11371018-B2
United States of America
Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy
Grant US-11365236-B2
United States of America
Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
Grant US-11312718-B2
United States of America
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
Application WO-2022061098-A1
World Intellectual Property Organisation (WIPO)
Mesoporous silica compositions comprising inflammatory cytokines comprising inflammatory…
Grant US-11278604-B2
United States of America
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
Grant US-11261251-B2
United States of America
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
Grant US-11253547-B2
United States of America
Solid forms of isoquinolinones, and process of making, composition comprising, and…
Grant US-11247995-B2
United States of America
Injectable, pore-forming hydrogels for materials-based cell therapies
Grant US-11202759-B2
United States of America
Cancer immunotherapy using CD19-directed chimeric antigen receptors
Grant US-11154575-B2
United States of America
Combination therapies
Grant US-11147818-B2
United States of America
Immune cell trapping devices and methods for making and using the same
Grant US-11150242-B2
United States of America
Immune cells engineered to express CD19-directed chimeric antigen receptors and uses…
Grant US-11141436-B2
United States of America
Combination therapies
Grant US-11110096-B2
United States of America
Scaffolds for cell transplantation
Grant US-11096997-B2
United States of America
EFFECTIVE GENERATION OF TUMOR-TARGETED T-CELLS DERIVED FROM PLURIPOTENT STEM CELLS
Application EP-3789487-A1
European Patent Office
Heterocyclic compounds and uses thereof
Grant US-10941162-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-10919914-B2
United States of America
Natural killer cells modified to express membrane-bound interleukin 15 and uses thereof
Grant US-10774311-B2
United States of America
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K…
Grant US-10759806-B2
United States of America
Combination vaccine devices and methods of killing cancer cells
Grant US-10682400-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-10675286-B2
United States of America
Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one…
Grant US-10550122-B2
United States of America
Modified natural killer cells that express IL15 and uses thereof
Grant US-10428305-B2
United States of America
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
Grant US-10370448-B2
United States of America
Effective generation of tumor-targeted T cells derived from pluripotent stem cells
Application US-10370452-B2
United States of America
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
Application EP-3508215-A2
European Patent Office
Heterocyclic compounds and uses thereof
Grant US-10329299-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-10253047-B2
United States of America
CD28 expression during lenalidomide immune modulation
Grant US-10241113-B2
United States of America
END-TO-END CELL THERAPY AUTOMATION
Application WO-2019046766-A2
World Intellectual Property Organisation (WIPO)
Solid forms of isoquinolinones, and process of making, composition comprising, and…
Grant US-10160761-B2
United States of America
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
Grant US-10011656-B2
United States of America
Human monoclonal antibodies to CTLA-4
Grant US-9963508-B2
United States of America
Chimeric receptors with 4-1BB stimulatory signaling domain
Grant US-9856322-B2
United States of America
Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one…
Grant US-9840505-B2
United States of America
Processes for preparing isoquinolinones and solid forms of isoquinolinones
Grant US-RE46621-E1
United States of America
Chimeric receptors with 4-1BB stimulatory signaling domain
Grant US-9834590-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9828377-B2
United States of America
Certain chemical entities, compositions and methods
Grant US-9822131-B2
United States of America
Heterocyclic kinase inhibitors
Grant US-9790228-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9775844-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9751888-B2
United States of America
Chemical compounds, compositions and methods for kinase modulation
Grant US-9738644-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9718815-B2
United States of America
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
Grant US-9708348-B2
United States of America
Certain chemical entities, compositions and methods
Grant US-9655892-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9605003-B2
United States of America
Chimeric receptors with 4-1BB stimulatory signaling domain
Grant US-9605049-B2
United States of America
CTLA-4 antibody dosage escalation regimens
Grant US-9573999-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9546180-B2
United States of America
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders…
Grant US-9527847-B2
United States of America
Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof
Grant US-9522146-B2
United States of America
Salts and solid forms of isoquinolinones and composition comprising and methods of using…
Grant US-9481667-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9388183-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9359365-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9315505-B2
United States of America
Heterocyclic kinase inhibitors
Grant US-9296742-B2
United States of America
Processes for preparing isoquinolinones and solid forms of isoquinolinones
Grant US-9290497-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9255108-B2
United States of America
Certain chemical entities, compositions and methods
Grant US-9216982-B2
United States of America
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
Grant US-9206182-B2
United States of America
Chemical compounds, compositions and methods for kinase modulation
Grant US-9181221-B2
United States of America
Substituted isoquinolinones and methods of treatment thereof
Grant US-9115141-B2
United States of America
Human anti-PD-1 antibodies and uses therefor
Grant US-9102727-B2
United States of America
CTLA-4 antibody dosage escalation regimens
Grant US-9062111-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-9056877-B2
United States of America
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal…
Grant US-9056906-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-8969363-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-8940742-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-8901133-B2
United States of America
Human monoclonal antibodies to CTLA-4
Grant US-8883984-B2
United States of America
EFFECTIVE GENERATION OF TUMOR-TARGETED T-CELLS DERIVED FROM PLURIPOTENT STEM CELLS
Application WO-2014165707-A2
World Intellectual Property Organisation (WIPO)
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders…
Grant US-8828998-B2
United States of America
Processes for preparing isoquinolinones and solid forms of isoquinolinones
Grant US-8809349-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-8785454-B2
United States of America
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
Grant US-8785456-B2
United States of America
Heterocyclic compounds and uses thereof
Grant US-8785470-B2
United States of America
Human CTLA-4 antibodies and their uses
Grant US-8784815-B2
United States of America
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
Application WO-2014089113-A1
World Intellectual Property Organisation (WIPO)
Heterocyclic kinase inhibitors
Grant US-8703778-B2
United States of America
Certain chemical entities, compositions and methods
Grant US-8703777-B2
United States of America
Showing items 1–100